United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet needs of patients with chronic and life-threatening conditions. The company's mission is to provide transformative therapies for diseases such as pulmonary arterial hypertension and organ transplantation. United Therapeutics employs a strategy centered on research and development, leveraging advanced technologies and collaborations to enhance patient outcomes. Through its commitment to innovation and patient care, United Therapeutics aims to improve the quality of life for individuals suffering from serious health challenges.

UNITED THERAPEUTICS CORP

United Therapeutics Corporation is making significant strides in the healthcare sector under the leadership of co-founder Martine Rothblatt. As a keynote speaker at the upcoming eMerge Americas Conference + Expo, scheduled for March 27-28, 2025, Rothblatt will discuss vital technological advancements that are shaping the future of health technology. This...

Martine Rothblatt to Represent United Therapeutics at eMerge Americas Conference as Company Strengthens Position in PAH and Cancer Treatment Markets

Martine Rothblatt is set to lead the conversation at the eMerge Americas Conference, highlighting United Therapeutics' innovative strides in PAH and cancer treatment. As competition intensifies, can the company leverage its technological advancements to sustain its market leadership?